Open-label Extension Study of Brazikumab in Ulcerative Colitis
Condition: Ulcerative Colitis Intervention: Biological: Brazikumab Sponsor: Allergan Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials